FI841925A0 - Nya indolfoereningar. - Google Patents
Nya indolfoereningar.Info
- Publication number
- FI841925A0 FI841925A0 FI841925A FI841925A FI841925A0 FI 841925 A0 FI841925 A0 FI 841925A0 FI 841925 A FI841925 A FI 841925A FI 841925 A FI841925 A FI 841925A FI 841925 A0 FI841925 A0 FI 841925A0
- Authority
- FI
- Finland
- Prior art keywords
- indolfoereningar
- nya
- nya indolfoereningar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/495,370 US4536505A (en) | 1983-05-17 | 1983-05-17 | Certain N-(pyridyl) indoles |
Publications (2)
Publication Number | Publication Date |
---|---|
FI841925A0 true FI841925A0 (fi) | 1984-05-14 |
FI841925A7 FI841925A7 (fi) | 1984-11-18 |
Family
ID=23968377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI841925A FI841925A7 (fi) | 1983-05-17 | 1984-05-14 | Nya indolfoereningar. |
Country Status (15)
Country | Link |
---|---|
US (1) | US4536505A (fi) |
EP (1) | EP0126401A1 (fi) |
JP (1) | JPS59212489A (fi) |
KR (1) | KR840009302A (fi) |
AU (1) | AU2809484A (fi) |
DD (1) | DD224588A5 (fi) |
DK (1) | DK242484A (fi) |
ES (5) | ES8602652A1 (fi) |
FI (1) | FI841925A7 (fi) |
GR (1) | GR79934B (fi) |
HU (1) | HUT34182A (fi) |
IL (1) | IL71832A0 (fi) |
NO (1) | NO841958L (fi) |
PT (1) | PT78582A (fi) |
ZA (1) | ZA843677B (fi) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
US4609733A (en) * | 1984-12-27 | 1986-09-02 | Ciba-Geigy Corporation | 3-keto-substituted-N-pyridylindoles |
US4758586A (en) * | 1985-02-01 | 1988-07-19 | Usv Pharmaceutical Corp. | Indolyl compounds and hyposensitivity use thereof |
US5039811A (en) * | 1987-04-24 | 1991-08-13 | Hoechst-Roussel Pharmaceuticals Inc. | Preparation of N-(pyridinyl)-1H-indol-1-amines |
US4970218A (en) * | 1987-04-24 | 1990-11-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-(pyridinyl)-1H-indol-1-amines |
US4880822A (en) * | 1987-04-24 | 1989-11-14 | Hoechst-Roussel Pharmaceuticals, Inc. | N-(pyridinyl)-1H-indol-1-amines |
US5550118A (en) * | 1994-01-31 | 1996-08-27 | Eli Lilly And Company | Polyhydronorharman synthase inhibitors |
US5977125A (en) * | 1994-10-31 | 1999-11-02 | Eisai Co., Ltd. | Mono-or polyenic carboxylic acid derivatives |
GB2295151B (en) * | 1994-11-18 | 1998-12-09 | Nmc | Polymerization of substituted heterocyclic monomers |
BR9908165A (pt) * | 1998-02-23 | 2000-10-31 | Univ South Alabama | Processos de prevenção de um citotóxico de proteìna beta amilóide em células, de tratamento de uma fibrilogênica em um sujeito humano, de diminuição da oxidação em uma amostra biológica e de tratamento de doenças ou outros quadros em que radicais livres e/ou tensão oxidativa desempenham um papel, e, uso de ácido indol-3-propiÈnico ou um seu sal ou éster. |
AU2002362603A1 (en) * | 2001-09-26 | 2003-04-07 | Bayer Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
JP2009513576A (ja) * | 2005-10-11 | 2009-04-02 | インターミューン・インコーポレーテッド | ウィルス複製のインヒビター |
KR100807718B1 (ko) * | 2006-10-17 | 2008-02-28 | 한국생명공학연구원 | 인돌 유도체를 유효성분으로 함유하는 대사성 질환 예방 및치료용 약학적 조성물 |
AU2008216382A1 (en) * | 2007-02-12 | 2008-08-21 | Array Biopharma, Inc. | Novel inhibitors hepatitis C virus replication |
ES2422284T3 (es) * | 2007-03-29 | 2013-09-10 | Daiichi Sankyo Co Ltd | Derivado de indol que tiene actividad inhibidora de cPLA2, uso del mismo y método para producirlo |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3449348A (en) * | 1968-01-08 | 1969-06-10 | Merck & Co Inc | Alpha-halomethyl-1-pyridine or quinoline carbonyl-3-indolylacetic acids |
AT299938B (de) * | 1971-02-03 | 1972-07-10 | Italiana Sint Spa | Verfahren zur Herstellung des neuen Natriumsalzes der (1-Nicotinoyl-2-methyl-5-methoxy-3-indolyl)-essigsäure, gegebenenfalls im Gemisch mit der freien Säure |
FR2171937A1 (en) * | 1972-02-16 | 1973-09-28 | Clin Midy | Aminoketo indoles - analgesics and antidepressants |
FR2171936B1 (fi) * | 1972-02-16 | 1975-04-25 | Clin Midy | |
AT323154B (de) * | 1973-02-02 | 1975-06-25 | Hurka Wilhelm | Verfahren zur herstellung von neuen 5-methoxy-2-methylindol-3-essigsäurederivaten sowie von deren salzen |
DE2862340D1 (en) * | 1978-02-01 | 1983-11-24 | Wellcome Found | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
US4322533A (en) * | 1980-03-17 | 1982-03-30 | Lesher George Y | 1H-Indole-2,3-dione derivatives |
US4363912A (en) * | 1980-12-15 | 1982-12-14 | Pfizer Inc. | Indole thromboxane synthetase inhibitors |
CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
GB2102795A (en) * | 1981-07-31 | 1983-02-09 | Pfizer Ltd | Indole derivatives |
US4478842A (en) * | 1981-11-19 | 1984-10-23 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
US4460777A (en) * | 1981-11-19 | 1984-07-17 | Ciba-Geigy Corporation | N-Substituted-2-pyridylindoles |
US4511573A (en) * | 1983-05-17 | 1985-04-16 | Ciba-Geigy Corporation | 3-Substituted-2-(heteroaryl) indoles |
-
1983
- 1983-05-17 US US06/495,370 patent/US4536505A/en not_active Expired - Fee Related
-
1984
- 1984-05-14 EP EP84105449A patent/EP0126401A1/de not_active Ceased
- 1984-05-14 FI FI841925A patent/FI841925A7/fi not_active Application Discontinuation
- 1984-05-15 IL IL71832A patent/IL71832A0/xx unknown
- 1984-05-15 JP JP59095771A patent/JPS59212489A/ja active Pending
- 1984-05-15 GR GR74706A patent/GR79934B/el unknown
- 1984-05-15 PT PT78582A patent/PT78582A/pt unknown
- 1984-05-16 HU HU841893A patent/HUT34182A/hu unknown
- 1984-05-16 KR KR1019840002658A patent/KR840009302A/ko not_active Withdrawn
- 1984-05-16 ZA ZA843677A patent/ZA843677B/xx unknown
- 1984-05-16 AU AU28094/84A patent/AU2809484A/en not_active Abandoned
- 1984-05-16 NO NO841958A patent/NO841958L/no unknown
- 1984-05-16 DD DD84263081A patent/DD224588A5/de unknown
- 1984-05-16 DK DK242484A patent/DK242484A/da not_active Application Discontinuation
- 1984-05-17 ES ES532572A patent/ES8602652A1/es not_active Expired
-
1985
- 1985-07-12 ES ES545154A patent/ES8604922A1/es not_active Expired
- 1985-07-12 ES ES545151A patent/ES8604195A1/es not_active Expired
- 1985-07-12 ES ES545153A patent/ES8604197A1/es not_active Expired
- 1985-07-12 ES ES545152A patent/ES8604196A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES8604197A1 (es) | 1986-01-16 |
ES8604922A1 (es) | 1986-02-16 |
AU2809484A (en) | 1984-11-22 |
DK242484D0 (da) | 1984-05-16 |
ES545152A0 (es) | 1986-01-16 |
ES545154A0 (es) | 1986-02-16 |
US4536505A (en) | 1985-08-20 |
ES532572A0 (es) | 1985-12-01 |
ES8604195A1 (es) | 1986-01-16 |
GR79934B (fi) | 1984-10-31 |
ZA843677B (en) | 1985-02-27 |
ES8602652A1 (es) | 1985-12-01 |
FI841925A7 (fi) | 1984-11-18 |
ES545151A0 (es) | 1986-01-16 |
KR840009302A (ko) | 1984-12-26 |
DD224588A5 (de) | 1985-07-10 |
ES545153A0 (es) | 1986-01-16 |
NO841958L (no) | 1984-11-19 |
EP0126401A1 (de) | 1984-11-28 |
PT78582A (en) | 1984-06-01 |
ES8604196A1 (es) | 1986-01-16 |
DK242484A (da) | 1984-11-18 |
HUT34182A (en) | 1985-02-28 |
JPS59212489A (ja) | 1984-12-01 |
IL71832A0 (en) | 1984-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI840547L (fi) | Nya farmakologiskt aktiva foereningar. | |
FI841759L (fi) | Foerfarande foer framstaellning av nya fluoralkoxifoereningar. | |
FI840824A0 (fi) | Nya azol-foereningar | |
FI842295L (fi) | Nya galeniska preparatformer foer orala antidiabetmedel och foerfarande foer deras framstaellning. | |
FI853171L (fi) | Nya guaninderivat. | |
FI842294A7 (fi) | Nya galeniska preparatformer foer orala antidiabetmedel och foerfarande foer deras framstaellning. | |
FI843043A7 (fi) | Nya organiska foereningar och deras farmaceutiska anvaendning. | |
FI852091A0 (fi) | Nya oktahydrobenso(f)kinolinfoereningar. | |
FI841758L (fi) | Foerfarande foer framstaellning av nya tricykliska etrar. | |
FI86987B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenylkinolinkarboxylsyraderivat. | |
FI840867A0 (fi) | Nya karboxamider | |
FI841259L (fi) | Nya farmaceutiska foereningar. | |
FI842960A0 (fi) | Nya herbicider i form av aminoetylfosfoner tillhoerande sulfonimiderna. | |
FI841925A0 (fi) | Nya indolfoereningar. | |
FI842813A7 (fi) | Nya synergistinderivat och foerfarande foer deras framstaellning. | |
FI842547A7 (fi) | Foerfarande foer framstaellning av nya spirosuckinimider. | |
FI842327L (fi) | Nya tiazolidinderivat. | |
FI841619A0 (fi) | Nya pyrimidonderivat. | |
FI843332A0 (fi) | Nya pesticidala heterocykliska foereningar. | |
FI844466A0 (fi) | Nya amidfoereningar. | |
FI73988B (fi) | Foerfarande foer framstaellning av nya kardiotoniskt verkande pyridinyl-2-pyrimidinaminderivat. | |
FI842724A7 (fi) | Nya farmaceutiska foereningar och deras framstaellning. | |
FI841376A0 (fi) | Nya oralt administrerbara galeniska former av sulpirid. | |
FI841731A0 (fi) | Nya acylaminofenolderivat. | |
FI842389A7 (fi) | Foerfarande foer framstaellning av nya bensofenoner. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Owner name: CIBA-GEIGY AG |